Business Description

UnitedHealth Group Inc
NAICS : 524114
SIC : 6324
ISIN : US91324P1021
Share Class Description:
XSGO:UNH: Ordinary SharesDescription
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.42 | |||||
Equity-to-Asset | 0.31 | |||||
Debt-to-Equity | 0.86 | |||||
Debt-to-EBITDA | 2.23 | |||||
Interest Coverage | 8.25 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.91 | |||||
Beneish M-Score | -2.26 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.7 | |||||
3-Year EBITDA Growth Rate | 2.2 | |||||
3-Year EPS without NRI Growth Rate | 15.2 | |||||
3-Year FCF Growth Rate | 2.3 | |||||
3-Year Book Growth Rate | 9.9 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 8.36 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 68.73 | |||||
9-Day RSI | 33.07 | |||||
14-Day RSI | 25.54 | |||||
3-1 Month Momentum % | -38.62 | |||||
6-1 Month Momentum % | -38.62 | |||||
12-1 Month Momentum % | -38.62 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.85 | |||||
Quick Ratio | 0.85 | |||||
Cash Ratio | 0.3 | |||||
Days Sales Outstanding | 21.3 | |||||
Days Payable | 76.33 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.77 | |||||
Dividend Payout Ratio | 0.3 | |||||
3-Year Dividend Growth Rate | 13.5 | |||||
Forward Dividend Yield % | 2.87 | |||||
5-Year Yield-on-Cost % | 5.48 | |||||
3-Year Average Share Buyback Ratio | 0.9 | |||||
Shareholder Yield % | 1.15 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 21.99 | |||||
Operating Margin % | 8.16 | |||||
Net Margin % | 5.39 | |||||
EBITDA Margin % | 8.88 | |||||
FCF Margin % | 6.06 | |||||
ROE % | 24.12 | |||||
ROA % | 7.48 | |||||
ROIC % | 11.21 | |||||
3-Year ROIIC % | 8.03 | |||||
ROC (Joel Greenblatt) % | 312.03 | |||||
ROCE % | 16.97 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat score | 9 | |||||
Tariff score | 9 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 13.66 | |||||
Forward PE Ratio | 13.77 | |||||
PE Ratio without NRI | 11.66 | |||||
Shiller PE Ratio | 18.63 | |||||
Price-to-Owner-Earnings | 11.41 | |||||
PEG Ratio | 1.48 | |||||
PS Ratio | 0.74 | |||||
PB Ratio | 3.12 | |||||
Price-to-Free-Cash-Flow | 12.16 | |||||
Price-to-Operating-Cash-Flow | 10.6 | |||||
EV-to-EBIT | 10.95 | |||||
EV-to-Forward-EBIT | 11.64 | |||||
EV-to-EBITDA | 9.7 | |||||
EV-to-Forward-EBITDA | 10.66 | |||||
EV-to-Revenue | 0.86 | |||||
EV-to-Forward-Revenue | 0.76 | |||||
EV-to-FCF | 14.2 | |||||
Price-to-GF-Value | 0.52 | |||||
Price-to-Projected-FCF | 0.82 | |||||
Price-to-DCF (Earnings Based) | 0.41 | |||||
Price-to-DCF (FCF Based) | 0.51 | |||||
Price-to-Median-PS-Value | 0.61 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.71 | |||||
Earnings Yield (Greenblatt) % | 9.13 | |||||
FCF Yield % | 8.4 | |||||
Forward Rate of Return (Yacktman) % | 13.89 |